BridgeBio Pharma
BBIO
NZ$66.39
Share price
-0.17%
Change (1 day)
50.69%
Change (1 year)
Categories
Market capitalization of BridgeBio Pharma (BBIO)
Market cap: NZ$12.60 Billion
As of June 2025 BridgeBio Pharma has a market cap of NZ$12.60 Billion. This makes BridgeBio Pharma the world's 2176th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of BridgeBio Pharma from 2019 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$12.60 B | 34.4% |
| 2024 | NZ$9.37 B | -15.54% |
| 2023 | NZ$11.10 B | 519% |
| 2022 | NZ$1.79 B | -50.09% |
| 2021 | NZ$3.59 B | -70.28% |
| 2020 | NZ$12.09 B | 87.9% |
| 2019 | NZ$6.43 B |
End of Day market cap according to different sources
On Jun 19th, 2025 the market cap of BridgeBio Pharma was reported to be:
NZ$12.60 Billion
NZ$12.60 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | NZ$34.69 M | -99.72% | 🇺🇸 USA |
 OPKO Health
OPK | NZ$1.69 B | -86.53% | 🇺🇸 USA |